Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.

Stocks | Futures | Watchlist | More
or

Merck & Company (MRK)

Merck & Company (MRK)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Profile for [[ item.sessionDateDisplayLong ]]

Company Info

Merck & Company 2000 GALLOPING HILL ROAD KENILWORTH NJ 07033 USA

P: 908-740-4000

Description:

Merck & Co., Inc., a leading global biopharmaceutical company known as MSD outside of the United States and Canada, has been inventing for life, bringing forward medicines and vaccines for many of the world's most challenging diseases. Through their prescription medicines, vaccines, biologic therapies and animal health products, they work with customers and operate the countries to deliver innovative health solutions. The Company also demonstrate their commitment to increasing access to health care through far-reaching policies, programs and partnerships. Merck continues to be at the forefront of research to advance the prevention and treatment of diseases that threaten people and communities around the world - including cancer, cardio-metabolic diseases, emerging animal diseases, Alzheimer's disease and infectious diseases including HIV and Ebola.

Key Statistics

Overview:

Market Capitalization, $K 199,953,744
Shares Outstanding, K 2,525,944
Annual Sales, $ 47,994 M
Annual Net Income, $ 7,067 M
Last Quarter Sales, $ 13,154 M
Last Quarter Net Income, $ 4,567 M
60-Month Beta 0.46
% of Insider Shareholders 0.32%
% of Institutional Shareholders 71.79%
Float, K 2,517,861
% Float 99.68%

Growth:

1-Year Return -1.12%
3-Year Return -0.23%
5-Year Return 29.49%
5-Year Revenue Growth 21.51%
5-Year Earnings Growth 65.46%
5-Year Dividend Growth 37.02%

Per-Share Information:

Most Recent Earnings 1.75 on 10/28/21
Next Earnings Date N/A
Earnings Per Share ttm 5.78
EPS Growth vs. Prev Qtr 33.59%
EPS Growth vs. Prev Year 0.57%
Annual Dividend Rate, $ 2.60
Annual Dividend Yield 3.16%
Most Recent Dividend 0.650 on 09/14/21
Next Ex-Dividends Date 09/14/21
Dividend Payable Date 10/07/21
Dividend Payout Ratio 105.74%
Most Recent Split 2-1 on 02/17/99

MRK Ratios

Ratio
Price/Earnings ttm 14.24
Price/Earnings forward 16.72
Price/Earnings to Growth 2.16
Return-on-Equity % 48.21%
Return-on-Assets % 16.00%
Profit Margin % 14.72
Net Margin % 6.13
Debt/Equity 0.72
Price/Sales 4.33
Price/Cash Flow 11.13
Price/Book 5.81
Book Value/Share 14.17
Interest Coverage 0.00

MRK Dividends

Date Value
09/14/21 $0.6500
06/14/21 $0.6500
03/12/21 $0.6500
12/14/20 $0.6500
09/14/20 $0.6100
06/12/20 $0.6100
03/13/20 $0.6100
12/13/19 $0.6100
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar